| Identification | Back Directory | [Name]
PotassiuM p-Tolyl Sulfate | [CAS]
91978-69-7 | [Synonyms]
PotassiuM p-Tolyl Sulfate
Potassiump-TolylSulfate>
Potassium p-Cresyl Sulfate
p-Cresol sulfate potassium
p-Cresyl sulfate potassium
p-Tolyl Sulfate PotassiuM Salt
p-Methylphenyl potassium sulfate
Potassium p-Tolyl Sulfate
p-Cresol sulfate (potassium salt)
Sulfuric Acid p-Tolyl Ester Potassium Salt
Sulfuric Acid p-Cresyl Ester Potassium Salt
p-Cresyl sulfate,Endogenous Metabolite,p-Tolyl sulfate,pCresyl sulfate potassium,p Cresyl sulfate potassium,inhibit,Inhibitor | [Molecular Formula]
C7H7KO4S | [MDL Number]
MFCD28100835 | [MOL File]
91978-69-7.mol | [Molecular Weight]
226.291 |
| Chemical Properties | Back Directory | [Melting point ]
189-193°C | [storage temp. ]
Hygroscopic, Refrigerator, Under inert atmosphere | [solubility ]
DMSO (Slightly), Water (Slightly) | [form ]
Solid | [color ]
White to Pale Yelllow | [biological source]
synthetic | [Stability:]
Hygroscopic |
| Hazard Information | Back Directory | [Uses]
p-Tolyl Sulfate is the major component of urinary myelin basic protein-like material and is derived through the secondary metabolism of p-cresol (C781900). | [in vivo]
p-Cresyl sulfate potassium (10 mg/kg intraperitoneal injection twice daily for 4 weeks) promotes insulin resistance associated with CKD in mice[2].
| Animal Model: | CKD mice modrl[2] | | Dosage: | 10 mg/kg | | Administration: | i.p. | | Result: | Increased fasting plasma glucose concentration and plasma cholesterol levels. |
| [IC 50]
Microbial Metabolite; Human Endogenous Metabolite |
|
|